Nutrition 21, Diabetex Form Alliance

Nutrition 21, Diabetex Form Alliance

PURCHASE, N.Y.--Nutrition 21 Inc. and DiabetexCorp. formed an alliance to conduct a clinical study on Diachrome, Nutrition21's patented combination of chromium picolinate and biotin. In the doubleblind, placebo-controlled study, researchers will investigate Diachrome's effecton glucose management and cholesterol levels in conjunction with prescriptionmedication in 600 patients with Type II diabetes.

"Nutrition 21's partnership with a well-respected,patient-focused disease management company like Diabetex represents asignificant milestone for our company as we move aggressively forward in thedevelopment and marketing of our chromium-based, patented portfolio of brandedproducts," said Gail Montgomery, president and chief executive officer ofNutrition 21 (www.nutrition21.com). Thecompany is also conducting a study in cooperation with Children's Hospital inOakland, Calif., to evaluate the efficacy of Diachrome in the juvenile Type IIdiabetes population.